Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » New GOLD report provides strategy for COPD
A summary of research published in the European Respiratory Journal
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published a new guide outlining a global strategy for the prevention, diagnosis and management of chronic obstructive pulmonary disease (COPD).
The report is one of the key resources in the field of COPD. It is updated every few years to include the latest research. This year’s report represents a major update, suggesting significant changes to how COPD is treated.
What’s new in this year’s report?
Why is this important?
The new report presents an opportunity to reconsider the diagnosis, management and treatment of COPD. It puts an emphasis on spotting COPD at an earlier stage, rather than waiting until the condition has progressed. In addition, the report summarises how we can better understand the causes and origin of COPD. This will help group the condition into different categories and enable better strategies to prevent the condition in the future.
You can view the 2023 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease at the GOLD website or read the published summary on the European Respiratory Journal’s website: Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79